Evaluating treatment options for low-risk thyroid cancer
Official title: Preference-Based Treatment Valuation in Low-Risk Thyroid Cancer
Funded at University of Maryland Baltimore · NIH-10947007 · Data updated 2026-11-12
This study is looking at how different treatment options for low-risk thyroid cancer, like active monitoring or surgery, affect patients' experiences and preferences, so we can better understand what matters most to you when choosing a treatment.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 17, 2024 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $279,039 |
| NIH project number | 1K08CA293167-01 |
| Project ID | NIH-10947007 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with low-risk papillary thyroid microcarcinoma who are considering treatment options.
✕Less likely to help
Patients with high-risk thyroid cancer or those who have already undergone treatment may not benefit from this research.
What this research studies
This research investigates the value of different treatment options for patients with low-risk thyroid cancer, specifically focusing on papillary thyroid microcarcinoma. It aims to understand patients' preferences and perceptions regarding their treatment experiences, which can vary significantly despite similar survival outcomes. By using patient-reported measures, the study will estimate the health state utilities associated with various therapies, including active surveillance and surgical options. The findings will help inform a cost-effectiveness model that compares these treatment strategies.
Why it matters
Potential benefit: If successful, this research could help tailor treatment options for low-risk thyroid cancer patients based on their preferences, potentially improving their quality of life.
How similar studies have gone: Previous research has shown that understanding patient preferences can significantly impact treatment decisions and outcomes, suggesting this approach has potential for success.
Where this research is happening
-
University of Maryland Baltimore
Baltimore, United States Active
Researchers
- Principal investigator: Hu, Yinin — University of Maryland Baltimore
- Study coordinator: Hu, Yinin
Related research
Other NIH-funded projects on the same topics.
-
WTC Dust and Thyroid Cancer Progression in Human Organoids
This grant tests how World Trade Center dust might influence thyroid cancer progression using human thyroid organoids to model real-life exposure.
-
Integrating molecular signals to guide thyroid cancer care
A doctor-scientist team at Brigham and Women’s Hospital is studying how tumor biology and the immune environment can guide personalized monitoring and treatment for differentiated thyroid cancer.
-
Metabolic Imaging to Track Treatment Response in Aggressive Thyroid Cancer
This grant explores a new way to watch how aggressive thyroid cancers respond to treatment using a special MRI technique that tracks tumor metabolism.
-
Adoptive T-cell Therapy for Anaplastic Thyroid Cancer
A patient-focused program explores using patient immune cells engineered to target and fight anaplastic thyroid cancer, especially for those whose cancer has stopped responding to standard treatments.
-
Overcoming Resistance to BRAF Inhibitors in Aggressive Thyroid Cancers
A patient-focused research effort to find new ways to treat difficult thyroid cancers that no longer respond to current BRAF inhibitors.
-
Improving Treatment of Anaplastic Thyroid Cancer with New Therapies and Early Response Checks
This NIH grant aims to advance treatment for a rare, aggressive thyroid cancer by testing new approaches and measuring how tumors respond early in treatment to tailor care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.